Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Merck
Colorcon
Express Scripts
Accenture
Federal Trade Commission
Cantor Fitzgerald
McKinsey
Julphar
Cerilliant

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090435

« Back to Dashboard

NDA 090435 describes CARBINOXAMINE MALEATE, which is a drug marketed by Cypress Pharm, Mikart, Vintage Pharms, Invagen Pharms, Mikart Inc, and Mission Pharmacal Co, and is included in nine NDAs. It is available from six suppliers. Additional details are available on the CARBINOXAMINE MALEATE profile page.

The generic ingredient in CARBINOXAMINE MALEATE is carbinoxamine maleate. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.
Summary for 090435
Tradename:CARBINOXAMINE MALEATE
Applicant:Invagen Pharms
Ingredient:carbinoxamine maleate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:Apr 15, 2010TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
Dow
Healthtrust
Federal Trade Commission
Moodys
Cantor Fitzgerald
Chinese Patent Office
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot